CoGenesys Receives FDA Clearance To Commence Clinical Trials Of Cardeva In Patients With Chronic Heart Failure

... CoGenesys, Inc. announced todaythat the U.S. Food and Drug Administration has completed its review of theCompany's Investigational New Drug (IND) application for Cardeva(TM), along- acting form of b-type natriuretic peptide (BNP), and that the Companyintends to begin clinical testing in the United States shortly, pendinginstitutional review board approval. [click link for full article] ...